Teresita De Guia

Impact of chronic obstructive pulmonary disease (COPD) in the Asia-Pacific region: the EPIC Asia population-based survey

Sam Lim, David Lam, Abdul Razak Muttalif et al. · Asia Pacific Family Medicine · 2015 · 173 citations · Full text

Medicine, Health Sciences, Disease Surveillance +10

Efficacy and safety of fluticasone furoate/vilanterol (50/25 mcg; 100/25 mcg; 200/25 mcg) in Asian patients with chronic obstructive pulmonary disease: a randomized placebo-controlled trial

Jinping Zheng, Teresita De Guia, Jie Wang‐Jairaj et al. · Current Medical Research and Opinion · 2015 · 52 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Asthma programmes in diverse regions of the world: challenges, successes and lessons learnt

Umesh Lalloo, Richard D. Walters, Masao Adachi et al. · The International Journal of Tuberculosis and Lung Disease · 2011 · 41 citations

Public Affairs, Chronic Disease Control, Health Policy +9

Evaluation of efficacy and safety of budesonide delivered via two dry powder inhalers

Edward Kerwin, David S. Pearlman, Teresita De Guia et al. · Current Medical Research and Opinion · 2008 · 13 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

A real-world evaluation of indacaterol and other bronchodilators in COPD: the INFLOW study

Georges Juvelekian, Waleed M. El-Sorougi, Chaicharn Pothirat et al. · International Journal of COPD · 2015 · 12 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17